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I would like to take a few moments to thank a few of the
individuals who have helped me at various stages of my
career. The honor that you give to me today must be shared
by those who have been so much a part of my surgical career
and my personal life.
First, my father, Ben. I regret that he couldn’t be here
today. His role modeling as a caring and dedicated surgeon
was undoubtedly the reason I chose surgery as my profes-
sion.
Next, Dr Frank Spencer, one of the great surgeons and
teachers of this past century. For 29 years, my surgical
education and professional career has been under his lead-
ership. To this day I call upon Dr Spencer for his wise
counsel. I am truly honored to hold the Chair to which he
brought such distinction for so many years.
Dr Anthony Imparato, my mentor and colleague for
many years. An excellent surgeon and respected teacher, Dr
Imparato incorporated the biology of vascular disease into
every clinical situation. I am grateful for his many lessons
and for the opportunities he has given me.
I want also to acknowledge my associates at NYU: Pat
Lamparello, a partner for 20 years; Mark Adelman; Glenn
Jacobowitz; Caron Rockman; Paul Gagne; Matt Nalban-
dian; and Neal Cayne. They have supported me in every
way. Thank you all. Also I want to thank Ronnie Landis,
RN, a part of our NYU vascular surgery team for more than
25 years. Her dedication and service as a research coordi-
nator and clinical nurse has been extraordinary.
Last, I thank Adriana, a lovely lady who caught my eye
about the same time I was first learning how to tie surgical
knots. As have many spouses of vascular surgeons, Adriana
has put up with late-night calls, early rises, and ruined social
engagements. In addition to raising our two sons, Adriana
has pursued her own profession as a teacher and kept it all
together with grace and charm.
It seems it was only yesterday that I attended my first
meeting of this organization. The year was 1976. The
meeting was held in Albuquerque, New Mexico. This
organization, at that time, was called the International
Cardiovascular Society. Dr Frank Spencer was our presi-
dent. I remember being in awe of the great surgeons at that
meeting: Michael DeBakey, Ed Wylie, Jessie Thompson,
Charles Rob, Robert Linton, Sterling Edwards, my men-
tors—Frank Spencer and Anthony Imparato—and many
other great men who had already contributed so much to
vascular surgery. (It was almost exclusively men in those
days, as few women had had the opportunity to pursue a
career in surgery in earlier years.) It was an unforgettable
experience for me.
By 1976, the profession of vascular surgery as we know
it had been in existence for approximately 25 years. In
medicine, as in all science, it is often difficult to pinpoint
exactly when an era began. Events are so closely intercon-
nected, with one contribution leading to another, that
naming any beginning or end is arbitrary. Certainly the first
half of the 20th century was the time of many exciting
discoveries in vascular surgery. Before 1950, however, the
actual number of vascular operations that had been per-
formed was relatively small. The successful aortic aneurysm
repair by Charles Dubost in 1951, using a homograft, was
a landmark event. Arguably, that was the beginning of
vascular surgery as we know it today. Within months of
Dubost’s report, homografts were being used elsewhere.
Another important event occurred in 1951: The Interna-
tional Society for Angiology, the forerunner of this organi-
zation, met for the first time.
What occurred over the next quarter-century was noth-
ing short of spectacular. In 1954, Dr Arthur Voorhees
reported the first successful use of a synthetic graft for
aneurysm repair. That same year, Drs Eastcott, Pickering,
and Rob reported on their successful carotid endarterec-
tomy. Year after year, new operations were described: ca-
rotid subclavian bypass in 1956, axillofemoral bypass in
1962. The Fogarty embolectomy catheter was introduced
in 1963. Dr Charles Dotter did the first angioplasty for an
arterial stenosis that same year. Over the next few years, a
variety of extra-anatomic bypasses for arch vessel recon-
struction were described. In 1973, Dr Lazar Greenfield
reported his success with the new filter for the vena cava.1
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Successful repair of vascular injuries, pioneered by Dr Spen-
cer and others during the Korean conflict, became com-
monplace for civilian injuries in the years after the war.
Few eras in the history of surgery have been so distin-
guished by discovery and innovation as has the quarter-
century that followed the first aortic reconstruction. Ad-
vances in cardiac surgery were even more spectacular. The
introduction of the heart-lung machine, synthetic valves,
coronary bypass, and heart transplantation were all intro-
duced before 1975. The effects of these discoveries on
other fields of medicine, and on health policy in general,
were remarkable. The public was eager to hear about these
exciting new discoveries. Newspapers and magazines regu-
larly reported advances in treatments for cardiac and vascu-
lar diseases. Public interest undoubtedly bolstered the po-
litical effort that led to the creation of Medicare in the
1950s and the federal funding for research for cardiovascu-
lar disease in the years that followed. One might argue that
the sociomedical progress of the 1960s and 1970s was as
much a result of as a contributing factor to the advances
that were occurring at the time.
To extol the glories of this early period is in no way to
discredit the generation that followed. If the first vascular
surgeons were the pioneers, those of the next generation
were the settlers. Dr George Johnson compared the early
and later periods in his presidential address titled, “The
Second Generation Vascular Surgeon.”2 Speaking to this
organization in 1986, Dr Johnson, after listing the achieve-
ments of the past decade, stated, “None of these has had
the impact of the vascular prosthesis, the techniques, and
the instrumentation [of the earlier generation].” He went
on to say, however, “I see my second generation colleagues
as quiet, but effective, contributors to progress in the field.
All of us are proud to have implemented the advances
developed by our predecessors.”2
As a part of that second generation, I too am very proud
of what our profession has accomplished during this last
quarter century. It has been a time of maturation of vascular
surgery as a discipline. Procedures have been refined; med-
ical devices have been perfected; operations have been
made safer. In addition, our generation has developed
training programs that have produced vascular surgeons of
the highest quality. Members of this second generation
have written textbooks, created highly respected journals,
and launched a Web site. Our clinical trials and multicen-
tered studies have resolved therapeutic dilemmas with sci-
entific evidence. We have established practice guidelines.
Our laboratories have added immense knowledge to the
basic science of vascular disease. We have provided quality
vascular surgery to virtually every community in this coun-
try and, indeed, to most parts of the world.
But to return to the earlier period, it is of interest to
think about what led to so many discoveries and so many
achievements during those first 25 years. Why then and not
earlier? In his book titled The Structure of Scientific Revolu-
tions, Thomas Kuhn discusses the fact that science does not
progress in a linear fashion.3 It is the way of science and
cultures in general that we oscillate between exploration
and development, between periods of discovery and peri-
ods of assimilation. As new concepts emerge, they must be
examined, tested, refined, and eventually incorporated into
the culture. But what fuels those bursts of creative energy
that characterize the periods of discovery?
Going back to our own profession, what fueled the
energy of those early years? Much credit has been given,
rightfully so, to the brilliant, creative individuals who were
associated with our early period. Would our early history
have been different without DeBakey, Rob, Szylagyi,
Wylie, Crawford, Thompson, and many others who fo-
cused their energies on vascular disease? The legendary
vision and work ethic of these great surgeons, mostly young
men at the time, was unquestionably a major factor in the
advances that occurred. But, if you think about the history
of vascular surgery, there have always been individuals with
great intellect and vision, such as Alexis Carrel and Rene
Leriche. Carrel, however, saw little application of his dis-
coveries of transplantation during his lifetime. Rene Le-
riche, who recognized the need for aortic bypass grafts, had
to wait more than 20 years before actually seeing such an
operation performed. Why did the work of these men not
unleash a torrent of creativity?
We know that great advances generally occur not in
isolation, but in conjunction with other events. What other
events, then, helped to fuel the discoveries of that first
quarter-century of vascular surgery? One factor was ad-
vances in other fields that were occurring simultaneously.
For example, at the end of World War II, the plastic
industry was emerging with new discoveries of all sorts.
Vinyon-N, the material used by Voorhees for his historic
aneurysm repair, was a product developed by Union Car-
bide, the chemical company. After creating Vinyon-N, the
company failed to find a suitable use for it. It wasn’t
satisfactory for sailcloth, for which it was intended. Union
Carbide was pleased to donate this new material to the dog
laboratory at Columbia University. From there it found its
way to become the first successful synthetic vascular graft.4
The advances in synthetics made possible new sutures,
flexible catheters, improved endotracheal tubes, heart
valves, components for the heart-lung machine, and many
other devices that were critical to the development of
cardiac and vascular surgery.
Contributions came from other fields as well. The
military and space industry provided new machines that
were used for measuring and monitoring of patients. New
surgical instruments of high quality—clamps, scissors, and
needles—were developed. Antibiotics and anticoagulants
were improved. New diagnostic machines for the evalua-
tion of vascular disease were invented. The early vascular
surgeons were quick to recognize the possible uses of these
new technologies and apply them to their work. Industry,
in response to the interests of surgeons, developed thou-
sands of new products for their use.
In addition to the men and the technology, a third
important factor was the vast number of patients with
vascular disease. Up until that point in time, medical care
for these patients had been limited or nonexistent. Thou-
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sands upon thousands of individuals were desperate for
treatment. The mere volume of procedures that needed to
be performed accelerated the rate of discovery immensely.
To put this into perspective, within the 4 years after the
Voorhees operation, the team at Baylor Medical Center
had performed more than 1000 aneurysm repairs with
synthetic grafts.4 The treatment knowledge gained from
the explosive demand spawned more new operations, new
innovations, and new technology.
This confluence of bright minds, new technology, and
a vast number of patients needing treatment resulted in one
of the most exciting chapters in medical history of all time.
Certainly all of the conditions were aligned for a major
advance in medicine. But that in itself was not enough. Had
not these early pioneers seized the opportunity created by
the confluence of these conditions, the evolution of vascu-
lar surgery may have occurred much differently. It took
great vision and courage, and it took youth—young sur-
geons not yet set in their ways. As Thomas Kuhn points out
in his book, “Almost always the men [and women] who
achieve these fundamental inventions of a new paradigm
have been either very young or very new to the field whose
paradigm they change.”3 It is usually the young, he ex-
plains, who have the courage to challenge older concepts
and to effect change. This axiom generally has been true in
our own profession. The excellent papers at this meeting,
for example, have been presented, for the most part, by
men and women in their 30s and 40s.
So what will the next 25 years be like? Where will our
profession go from here? Only a few years ago, some were
bemoaning the fact that the great age of vascular surgery
was over. The development of bypass grafts and vascular
procedures had reached its peak. It seemed that interven-
tionists with their balloons and stents were taking over.
Interestingly, only 4 years after Dr Johnson brought
attention to the fact that vascular surgeons of the second
generation had not produced discoveries as significant as
the synthetic graft, Dr Juan Parodi announced his success-
ful repair of an aneurysm with an endograft. The excite-
ment of this event rippled through our profession. Sur-
geons around the globe began to experiment with graft
designs and delivery devices. New industries developed to
produce grafts. By the late 1990s, surgeons across the
country were being trained in the new technology, and
patients were benefiting from the new method of treating
abdominal aortic aneurysms. Last year, more than 19,000
endografts were used in the United States alone.
The skills necessary for inserting endografts prompted
our vascular surgeons to learn catheter techniques. In a few
short years, our residency programs incorporated endovas-
cular training as part of the curriculum. Vascular surgeons
coming out of these programs today are as skilled with
catheters and stents as they are with sutures and needle
holders.
Many other procedures and scores of devices have
stemmed from the work on aortic endografts. Endografts
of all shapes and sizes and purposes have been developed.
Cerebral protection devices for safer carotid stent place-
ment are being designed and built. New catheters, guide-
wires, and balloons have been produced. A walk through
the exhibits of this meeting will give you a glimpse of the
products that have been developed in the past few years as
a result of our interest in endovascular surgery. In addition,
we are seeing new medications for thrombolysis and anti-
coagulation. Drug-eluding stents will soon be available.
Gene therapy is being investigated. We have new machines
for diagnosing vascular disease. We are in the midst of a
technology surge that is equal to, if not greater than, that at
the time of the birth of our profession.
As this new technology becomes available, we are for-
tunate to have bright young surgeons who are able to make
effective use of it. The young surgeons presenting at this
meeting are only a reflection of the hundreds of talented
young surgeons in our ranks. At a recent Fellows Night in
New York, the level of basic science and clinical research
presented by vascular surgery residents was astounding.
Vascular surgery is blessed with some of the best minds in
medicine today.
All of this new technology and surgeons skilled at using
it come none too soon. We are already seeing an increase in
the number of patients who need treatment for vascular
disease. As the members of the Baby Boom age, the num-
ber of elderly will continue to expand disproportionately to
the rest of the population. At the beginning of this century,
there were approximately 35 million Americans aged over
65 years. By 2015, that number will be 50 million, and by
2030 that will expand to 70 million.5 The demand for early
diagnosis and treatment will further magnify the need for
more vascular professionals in the future.
If you look closely at what is happening around us, you
will appreciate the fact that the circumstances of today are
not unlike those that existed 50 years ago—bright young
surgeons, new technology, and a growing population in
need of vascular care. It is my view that we are at the
beginning of another dynamic era of innovation and dis-
covery. A new period of scientific advance is already well
underway. The opportunity for making significant contri-
butions in the years to come is extraordinary—not only
contributions to the treatment of vascular diseases, but also
major advances in prevention of vascular disease. One can
hope that the energy that will drive this next period of
discovery will also bring solutions to many of the medical-
social problems of today—the rising costs of medical care
and our inability to provide quality care to all members of
our society.
Is it possible that among us today are vascular surgeons
who will harness angiogenesis so that we will be able to
grow new blood vessels for ischemic limbs? Is it possible
that surgeons of the future will be busy applying catheter-
directed medicines to the lining of arteries to reverse plaque
formation? Will physicians someday be able to predict in
advance which individuals will develop aneurysms and then
be able to prevent those aneurysms before they occur? Will
we have an effective vascular screening program for our
society? All of these are not only possible, but very likely. I
expect that individuals in this room will be leading these
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efforts. There is one thing I can say about the future with
certainty—that is that by year 2025 there will be new
devices, new medicines, new treatments, and new machines
for diagnosis that are beyond the imagination of anyone in
this room.
But remember that bright minds, new technology, and
need are not the only ingredients for a major scientific
advance. It also takes courage and hard work on the part of
those who can effect the change. Those who will lead the
way must seize the opportunities and make the most of each
and every one. I know there are young surgeons in this
room today who will do exactly that. There will be many
challenges along the way. The competition from cardiology
will be severe. But I do believe that vascular surgery as a
profession will prevail. We have been studying and treating
vascular diseases for 50 years, and we do it best.
The coming years will be an extraordinary period for
vascular surgery and for all of the young surgeons who will
be a part of it. The contributions that you will make to our
profession and to our society will likely be greater than all
those that have proceeded. I will look forward to being with
you at these meetings in the years to come, to marvel at
what your generation will create. I believe that young
surgeons of today will make this next quarter-century our
very best.
In closing, I want to thank all of you who have given me
the extraordinary privilege to serve as an officer of this
society for the past 6 years. Being your president has been
the high point of my surgical career. The transitions that
have taken place during these few years have been phenom-
enal. We will be soon voting on yet another change in our
organization. I am convinced that the convergence of the
Society for Vascular Surgery and the American Association
for Vascular Surgery is an important next step to building
the strong organization that we need for the future that I
have envisioned today.
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